Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats

OBJECTIVE: The clinical use of doxorubicin, which is a strong antineoplastic agent, is limited due to its cardiotoxic side effects. Metformin is a drug with antihyperglycemic effects, and it has been shown to have a cardioprotective effect on left ventricular function in experimental animal models o...

Descripción completa

Detalles Bibliográficos
Autores principales: Argun, Mustafa, Üzüm, Kazım, Sönmez, Mehmet Fatih, Özyurt, Abdullah, Karabulut, Derya, Soyersarıca, Zeynep, Çilenk, Kübra Tuğçe, Unalmış, Sunay, Pamukcu, Özge, Baykan, Ali, Narin, Figen, Elmalı, Ferhan, Narin, Nazmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368431/
https://www.ncbi.nlm.nih.gov/pubmed/26642465
http://dx.doi.org/10.5152/akd.2015.6185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368431/
https://www.ncbi.nlm.nih.gov/pubmed/26642465
http://dx.doi.org/10.5152/akd.2015.6185

Ejemplares similares